Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KRT17P6 (Keratin 17 pseudogene 6) is a member of the keratin pseudogene subfamily, representing a non-functional genomic sequence with high similarity to the protein-coding KRT17 gene. Unlike the active KRT17 gene, which encodes a type I intermediate filament protein involved in maintaining epithelial structure and disease, KRT17P6 does not code for a functional protein and has no recognized role as a therapeutic target. The presence of "pseudogene" in its name and relevant literature confirms its non-coding status and lack of direct biological or disease relevance[5]. If you intended to ask about the functional KRT17 gene or protein, which is associated with diseases and biological functions in the skin and other epithelia, please clarify for detailed information on that target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 17 pseudogene 6 (KRT17P6).